06 Jul 2021 | 02:45 PM GMT

Routes to market for Virtual Care in Cardiovascular Diseases

About this Meeting

What are the best routes to market for virtual care companies in the cardiovascular space? 

 Cardiovascular Diseases (CVDs) such as heart failure, hypertension, coronary artery disease amongst others, are leading causes of death globally. Since symptoms and signs can be easily measured by technology, CVD is one of the areas that has benefited the most from Remote Patient Monitoring (RPM) programs so far, showing promising clinical and economic outcomes on multiple occasions. But beyond evidence and outcomes, choosing the right route to market is a big challenge for digital health companies operating in this space. Join us in this informal conversation where we will discuss: 
  •  What are the most scalable and sustainable commercialization models for Virtual Care companies in the cardiovascular space? Keys to success?
  •  Factors that determine the best route to market (e.g geographies, disease, objective of the program -prevention, diagnosis, management, etc-, others) 
  •  Implications of choosing one route to market vs. others (evidence requirements, pricing strategies, organization structure of the company, etc)